Point72 Asset Management »

Caris Life Sciences shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.5M 247k 30.25
2025-06-30 $12M 459k 26.72

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
Coatue Management
FMR
T. Rowe Price Investment Management
Braidwell
Silver Lake Group
Neuberger Berman Group
Millennium Management
PointState Capital
OrbiMed Advisors
Ameriprise Financial
ClearBridge Advisors
Canada Pension Plan Investment Board
Alliancebernstein
Ubs Global Asset Management Americas

View all funds holding Caris Life Sciences